D.A. Davidson & CO. increased its holdings in shares of CRH plc (NYSE:CRH – Free Report) by 32.4% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 8,762 shares of the construction company’s stock after purchasing an additional 2,144 shares during the period. D.A. Davidson & CO.’s holdings in CRH were worth $813,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently bought and sold shares of the business. Cetera Investment Advisers increased its holdings in shares of CRH by 286.4% during the 1st quarter. Cetera Investment Advisers now owns 54,148 shares of the construction company’s stock worth $4,671,000 after acquiring an additional 40,135 shares during the last quarter. Cetera Advisors LLC bought a new position in shares of CRH in the first quarter valued at about $1,277,000. Transcend Capital Advisors LLC acquired a new stake in shares of CRH during the 2nd quarter worth about $272,000. Kingswood Wealth Advisors LLC bought a new stake in shares of CRH during the 2nd quarter worth about $591,000. Finally, Park Avenue Securities LLC grew its stake in CRH by 11.1% in the 2nd quarter. Park Avenue Securities LLC now owns 29,102 shares of the construction company’s stock valued at $2,169,000 after buying an additional 2,896 shares during the last quarter. Institutional investors and hedge funds own 62.50% of the company’s stock.
Wall Street Analysts Forecast Growth
CRH has been the subject of a number of research analyst reports. Morgan Stanley boosted their price objective on CRH from $95.00 to $104.00 and gave the stock an “overweight” rating in a report on Monday, November 11th. HSBC began coverage on CRH in a research note on Monday, November 11th. They issued a “buy” rating and a $116.00 price target for the company. Truist Financial lifted their target price on CRH from $110.00 to $120.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Hsbc Global Res upgraded shares of CRH to a “strong-buy” rating in a research note on Monday, November 11th. Finally, JPMorgan Chase & Co. raised their price target on shares of CRH from $114.00 to $116.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 20th. One equities research analyst has rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, CRH currently has a consensus rating of “Buy” and a consensus price target of $106.42.
CRH Price Performance
NYSE CRH opened at $102.46 on Tuesday. CRH plc has a fifty-two week low of $62.80 and a fifty-two week high of $104.19. The business has a fifty day moving average price of $95.37 and a two-hundred day moving average price of $86.35. The stock has a market capitalization of $69.59 billion, a PE ratio of 20.49, a PEG ratio of 1.29 and a beta of 1.29.
CRH Cuts Dividend
The firm also recently announced a Variable dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Friday, November 22nd will be given a $0.262 dividend. This represents a yield of 1.4%. The ex-dividend date of this dividend is Friday, November 22nd. CRH’s dividend payout ratio is presently 37.20%.
About CRH
CRH plc, together with its subsidiaries, provides building materials solutions in Ireland and internationally. It operates through four segments: Americas Materials Solutions, Americas Building Solutions, Europe Materials Solutions, and Europe Building Solutions. The company provides solutions for the construction and maintenance of public infrastructure and commercial and residential buildings; and produces and sells aggregates, cement, readymixed concrete, and asphalt, as well as provides paving and construction services.
Featured Stories
- Five stocks we like better than CRH
- How to Evaluate a Stock Before BuyingÂ
- How to Master Trading Discipline: Overcome Emotional Challenges
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Receive News & Ratings for CRH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH and related companies with MarketBeat.com's FREE daily email newsletter.